| FLOW Cryptocurrency Investor News: If You Have Suffered Losses in FLOW Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
04/21 |
20:52 |
| ROSEN, A LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR |
Globe Newswire |
04/21 |
20:39 |
| ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hercules Capital, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HTGC |
Globe Newswire |
04/21 |
20:34 |
| ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE |
Globe Newswire |
04/21 |
20:33 |
| Crypto News: AlphaPepe Stage 13 Sold Out Whilst Ethereum Price Prediction Targets $12,000 |
Globe Newswire |
04/21 |
20:30 |
| pHemmePure Claims Evaluated: Feminine UTI Balance Formula for Vaginal pH Support by Board-Certified Urologist |
Globe Newswire |
04/21 |
20:07 |
| ROSEN, A LEADING LAW FIRM, Encourages Coty Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – COTY |
Globe Newswire |
04/21 |
20:04 |
| Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment |
Globe Newswire |
04/21 |
20:00 |
| Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026 |
Globe Newswire |
04/21 |
20:00 |
| ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX |
Globe Newswire |
04/21 |
19:53 |
| Triple Green Farms CBD Gummies Claims Evaluated: The Best CBD Gummy Formula on the Market Under Investigation |
Globe Newswire |
04/21 |
19:41 |
| ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– SLNO |
Globe Newswire |
04/21 |
19:31 |
| ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TCOM |
Globe Newswire |
04/21 |
19:16 |
| Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting |
Globe Newswire |
04/21 |
18:45 |
| RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol |
Globe Newswire |
04/21 |
18:44 |
| ROSEN, LEADING INVESTOR COUNSEL, Encourages Gartner, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IT |
Globe Newswire |
04/21 |
18:36 |
| ROSEN, A TOP RANKED INVESTOR RIGHTS LAW FIRM, Encourages Stellantis N.V. Securities Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA |
Globe Newswire |
04/21 |
18:28 |
| REMINDER: Super Micro Computer, Inc. Investors With Significant Losses Must Act By May 25, 2026 - contact Kirby McInerney LLP |
Globe Newswire |
04/21 |
18:15 |
| Aeroméxico Reports Unaudited First Quarter 2026 Results |
Globe Newswire |
04/21 |
18:00 |
| Flixy TV Stick Under Investigation: Discover the Shocking Truth About Smart TV USB Device for Streaming Entertainment & Media |
Globe Newswire |
04/21 |
17:48 |
| Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting |
Globe Newswire |
04/21 |
17:35 |
| Equus Announces Fourth Quarter Net Asset Value |
Globe Newswire |
04/21 |
17:31 |
| Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 |
Globe Newswire |
04/21 |
17:30 |
| BBOT Presents Preclinical Data Showing RAS:PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026 |
Globe Newswire |
04/21 |
17:30 |
| Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 |
Globe Newswire |
04/21 |
17:30 |
